Comparison of rat and human cytochrome P450 (CYP) sources of N-alkylprotoporphyrin IX. Formation after interaction with porphyrinogenic xenobiotics: Studies with cDNA-expressed single CYP enzymes

Xenobiotica

Volumn 32, Issue 11, 2002, Pages 997-1006

  Gamble, J T ^a   Nakatsu, K ^a   Marks, G S ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2B1; CYTOCHROME P450 2C; CYTOCHROME P450 2C11; CYTOCHROME P450 3A2; PROTOPORPHYRIN; XENOBIOTIC AGENT; CYP2C11 PROTEIN, RAT; CYP2C6 PROTEIN, RAT; CYP3A2 PROTEIN, RAT; MEMBRANE PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STEROID 16ALPHA MONOOXYGENASE; STEROID 21 MONOOXYGENASE; UNSPECIFIC MONOOXYGENASE;

ARTICLE; COMPARATIVE STUDY; ENZYME ANALYSIS; ENZYME INACTIVATION; FLUOROMETRY; HEME SYNTHESIS; HUMAN; INSECT CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; ANIMAL; BACULOVIRUS; CELL LINE; CHEMISTRY; INSECT; METABOLISM; MICROSOME; SPECTROFLUOROMETRY;

ANIMALIA; INSECTA; UNIDENTIFIED BACULOVIRUS;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BACULOVIRIDAE; CELL LINE; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; HUMANS; INSECTS; MEMBRANE PROTEINS; MICROSOMES; NADP; PROTOPORPHYRINS; RATS; SPECTROMETRY, FLUORESCENCE; STEROID 16-ALPHA-HYDROXYLASE; STEROID 21-HYDROXYLASE; XENOBIOTICS;

EID: 0036849916     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/0049825021000012637     Document Type: Article

References (15)

1. Bornheim, L. M., Underwood, M. C., Caldera, P., Rettie, A. E., Trager, W. F., Wrighton, S. A. and Correia, M. A., 1987, Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: Mechanistic implications. Molecular Pharmacology, 32, 299-308.
2. De Matteis, F., Gibbs, A. H., Cantoni, L. and Francis, J., 1980, Substrate-dependent irreversible inactivation of cytochrome P-450: Conversion of its haem moiety into modified porphyrins. Ciba Foundation Symposium, 76, 119-139.
3. De Matteis, F. and Marks, G. S., 1996, Cytochrome P450 and its interactions with the heme biosynthetic pathway. Canadian Journal of Physiology and Pharmacology, 74, 1-8.
4. Lavigne, J. A., Nakatsu, K. and Marks, G. S., 2002, Identification of human hepatic Cytochrome P450 sources of N-alkylprotoporphyrin IX after interaction with porphyrinogenic xenobiotics. Drug Metabolism and Disposition 30, 788-794.
5. Marks, G. S., McCluskey, S. A., Mackie, J. E., Riddick, D. S. and James, C. A., 1988, Disruption of hepatic heme biosynthesis after interaction of xenobiotics with cytochrome P-450. FASEB Journal, 2, 2774-2783.
6. McNamee, J. P. and Marks, G. S., 1996, Cytochrome P4503A is the major source of N-vinylprotoporphyrin IX formation after administration of 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone to untreated and dexamethasone-pretreated rats. Drug Metabolism and Disposition, 24, 872-878.
7. Ortiz de Montellano, P. R. and Correia, M. A., 1996, Inhibition of cytochrome P450 enzymes. In P. R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry (New York: Plenum), pp. 305-364.
8. Ortiz de Montellano, P. R. and Grab, L. A., 1986, Inactivation of cytochrome P450 during catalytic oxidation of a 3-[(arylthio)ethyl]sydnone: N-vinyl heme formation via insertion into the Fe-N Bond. Journal of the American Chemical Society, 108, 5584-5589.
9. Ortiz de Montellano, P. R. and Mico, B. A., 1981, Destruction of cytochrome P-450 by allylisopropylacetamide is a suicidal process. Archives in Biochemistry and Biophysics, 206, 43-50.
10. Riddick, D. S., Park, S. S., Gelboin, H. V. and Marks, G. S., 1990, Effects of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on hepatic cytochrome P-450 heme, apoproteins, and catalytic activities following in vivo administration to rats. Molecular Pharmacology, 37, 130-136.
11. Rodrigues, A. D., 1999, Integrated cytochrome P450 reaction phenotyping: Attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochemical Pharmacology, 57, 465-480.
12. Sutherland, E. P., Marks, G. S., Grab, L. A. and Ortiz de Montellano P. R, 1986, Porphyrinogenic activity and ferrochelatase-inhibitory activity of sydnones in chick embryo liver cells. FEBS Letters, 197, 17-20.
13. Tephly, T. R., Gibbs, A. H. and de Matteis, F., 1979, Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Role of a porphyrin-like inhibitor of protohaem ferro-lyase. Biochemical Journal, 180, 241-244.
14. Wong, S. G., Kobus, S. M., McNamee, J. P. and Marks, G. S., 1998, Gender differences in N-alkyl protoporphyrin IX production in rats after the administration of porphyrinogenic xenobiotics. Drug Metabolism and Disposition, 26, 739-744.
15. Wong, S. G., Lin, E. H. and Marks, G. S., 1999, Cytochrome CYP sources of N-alkylproroporphyrin IX after administration of porphyrinogenic xenobiotics to rats. Drug Metabolism and Disposition, 27, 960-965.